Form 4 for RNXT RenovoRx, Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-21 · accession 0001493152-25-024875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-24 | 2025-11-21+ | RNXT | Agah Ramtin | Chief Medical Off, Dir | P - Purchase | $0.8 | +22.0K | 744.5K | +3% | +$17.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | P | A | 12,000 | $0.8 | 756,460 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. |
| 2 | Common | Common Stock | 2025-11-21 | P | A | 10,000 | $0.8 | 744,460 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. |